Value through Innovation27 July 2016

Clinical Study Results

  • PRADAXA ® - Coronary Disease
    Clinical Study Number 1160.67
    Study Indication Coronary Disease
    Product PRADAXA ®
    Generic Name Dabigatran
    Lab Code
    Clinical Phase II
    Study Title

    RandomizEd Dabigatran Etexilate dose finding study in patients with acute coronary syndromes post index Event with additional risk factors for cardiovascular complications also receiving aspirin and clopidogrel: Multi-centre, prospective, placebo-controlled, group dose escalation trial (RE-DEEM STUDY)

    Study Document Trial synopsis 1160.67_DR english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.